Spruce Biosciences recently announced that its candidate drug TA-ERT for Sanfilippo syndrome type B (also known as MPS IIIB) received positive feedback during a Type B meeting with the U.S. Food and Drug Administration (FDA).

老虎证券2026/02/18 12:16

Show original

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

You may also like

Toshiba launches 3,300V SiC MOSFET module for industrial equipment

Bitget•2026/09/24 02:23

Data centers drive the boom in U.S. non-residential construction; UBS highlights Caterpillar (CAT.US) and other potential beneficiary stocks

Non-residential construction starts in the United States continued to expand in August, as a significant increase in data center projects helped offset the impact of sluggish infrastructure starts.

智通财经•2026/09/24 02:16

Crypto Skills Technology | Skillful Use of TD for Chasing Highs in a Bull Market

AiCoin•2026/09/24 02:09

Qualcomm (QCOM.US) acquires robotics software company PickNik to strengthen its presence in the physical AI field

Qualcomm announced on Wednesday that it will acquire the robotics software company PickNik to enhance its presence in the field of physical AI and robotics.

智通财经•2026/09/24 01:16